MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy

International Journal of Cardiology

Volumn 175, Issue 3, 2014, Pages 409-417

  Ferreira, Ludmila Rodrigues Pinto ^a,b   Frade, Amanda Farage ^a,b   Santos, Ronaldo Honorato Barros ^a   Teixeira, Priscila Camillo ^a,b,d   Baron, Monique Andrade ^a,b   Navarro, Isabela Cunha ^a,b   Benvenuti, Luiz Alberto ^a   Fiorelli, Alfredo Inácio ^a   Bocchi, Edimar Alcides ^a   Stolf, Noedir Antonio ^a   Chevillard, Christophe ^c   Kalil, Jorge ^a,b   Cunha Neto, Edecio ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute of Investigation in Immunology iii   (Brazil)

^c AIX MARSEILLE UNIVERSITY   (France)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Chagas disease; Heart; miRNA; Trypanosoma cruzi

Indexed keywords

CYCLIN D1; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 133B; MICRORNA 208A; MICRORNA 208B; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN1 MICRORNA, HUMAN; MIRN133 MICRORNA, HUMAN; MIRN208 MICRORNA, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CHAGAS DISEASE; CHRONIC CHAGAS DISEASE CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYCLIN D1 GENE; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN TISSUE; MALE; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; YOUNG ADULT; BIOSYNTHESIS; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; GENE REGULATORY NETWORK; GENETICS; HEART MUSCLE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; FEMALE; GENE REGULATORY NETWORKS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIUM; YOUNG ADULT;

EID: 84905053130     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.05.019     Document Type: Article

References (31)

1. J. Cortez, R. Providencia, and E. Ramos et al. Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries World J Cardiol. 4 2012 234 239
2. E.A. Bocchi, G. Guimaraes, and F. Tarasoutshi et al. Cardiomyopathy, adult valve disease and heart failure in South America Heart. 95 2009 181 189
3. E. Cunha-Neto, V.J. Dzau, and P.D. Allen et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy Am J Pathol. 167 2005 305 313
4. V. Ambros MicroRNAs and developmental timing Curr Opin Genet Dev. 21 2011 511 517
5. V. Ambros The functions of animal microRNAs Nature. 431 2004 350 355
6. J.C. Carrington, and V. Ambros Role of microRNAs in plant and animal development Science. 301 2003 336 338
7. X. Karp, and V. Ambros Developmental biology Encountering microRNAs in cell fate signaling. Science. 310 2005 1288 1289
8. W.J. Yang, D.D. Yang, and S. Na et al. Dicer is required for embryonic angiogenesis during mouse development J Biol Chem. 280 2005 9330 9335
9. M. Bhaskaran, and M. Mohan MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease Vet Pathol. 51 4 2013 Sep 17 759 774
10. S. Hagiwara, and P. Kantharidis Cooper M. E. microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease. Curr Pharm Des. 20 2014 2347 2370
11. P. Lau, K. Bossers, and R. Janky et al. Alteration of the microRNA network during the progression of Alzheimer's disease EMBO Mol Med. 5 2013 1613 1634
12. D. Zhang, X. Li, and C. Chen et al. Attenuation of p38-mediated miR-1/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration PLoS One. 7 2012 e41478
13. C.A. Nascimento, V.A. Gomes, and S.K. Silva et al. Left Atrial and Left Ventricular Diastolic Function in Chronic Chagas Disease J Am Soc Echocardiogr. 26 2013 1424 1433
14. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat Protoc. 3 2008 1101 1108
15. I. Elzenaar, Y.M. Pinto, and R.J. Van Oort MicroRNAs in Heart Failure: New Targets in Disease Management Clin Pharmacol Ther. 94 2013 480 489
16. B. Vogel, A. Keller, and K.S. Frese et al. Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure Eur Heart J. 34 2013 2812 2823
17. Y. Hua, Y. Zhang, and J. Ren IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a J Cell Mol Med. 16 2012 83 95
18. C. Glass, and D.K. Singla ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium Mol Cell Biochem. 357 2011 135 141
19. A. Care, D. Catalucci, and F. Felicetti et al. MicroRNA-133 controls cardiac hypertrophy Nat Med. 13 2007 613 618
20. T.E. Callis, K. Pandya, and H.Y. Seok et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice J Clin Invest. 119 2009 2772 2786
21. Y. Fujio, T. Nguyen, and D. Wencker et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart Circulation. 101 2000 660 667
22. Y. Fujio, and K. Walsh Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner J Biol Chem. 274 1999 16349 16354
23. T. Matsui, T. Nagoshi, and E.G. Hong et al. Effects of chronic Akt activation on glucose uptake in the heart Am J Physiol Endocrinol Metab. 290 2006 E789 E797
24. R. Kumarswamy, A.R. Lyon, and I. Volkmann et al. SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway Eur Heart J. 33 2012 1067 1075
25. M.J. Kang, J.S. Kim, and S.W. Chae et al. Cyclins and cyclin dependent kinases during cardiac development Mol Cells 7 1997 360 366
26. P.K. Busk, and R. Hinrichsen Cyclin D in left ventricle hypertrophy Cell cycle. 2 2003 91 95
27. A. Hotchkiss, J. Robinson, and J. MacLean et al. Role of D-type cyclins in heart development and disease Can J Physiol and Pharmacol. 90 2012 1197 1207
28. F. Nagajyothi, M. Desruisseaux, and B. Bouzahzah et al. Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis Cell cycle. 5 2006 107 112
29. X. Yu, and D.C. Kem Proteasome inhibition during myocardial infarction Cardiovas Res. 85 2010 312 320
30. J.M. Predmore, P. Wang, and F. Davis et al. Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies Circulation. 121 2010 997 1004
31. S. Schlossarek, and L. Carrier The ubiquitin-proteasome system in cardiomyopathies Curr Opin Cardiol. 26 2011 190 195